49,260
edits
Difference between revisions of "Small cell carcinoma of the lung"
Jump to navigation
Jump to search
Small cell carcinoma of the lung (view source)
Revision as of 22:49, 16 January 2025
, 22:49, 16 January 2025→Molecular subtypes via IHC
| Line 118: | Line 118: | ||
! Notes | ! Notes | ||
|- | |- | ||
|ASCL1+ / NeuroD1- | |ASCL1 +ve / NeuroD1 -ve | ||
|41% | |41% | ||
| | |TTF-1 +ve | ||
| | | | ||
|- | |- | ||
|ASCL1+ / NeuroD1+ | |ASCL1 +ve / NeuroD1 +ve | ||
|37% | |37% | ||
| | |TTF-1 +ve | ||
| | | | ||
|- | |- | ||
|ASCL1- / NeuroD1+ | |ASCL1 -ve / NeuroD1 +ve | ||
|8% | |8% | ||
| | |TTF-1 +ve | ||
| | | | ||
|- | |- | ||
|ASCL1- / NeuroD1- | |ASCL1 -ve / NeuroD1 -ve | ||
|14% | |14% | ||
| | |TTF-1 -ve | ||
|includes all POU2F3+ cases which are ~9% of small cell carcinoma | |includes all POU2F3 +ve cases which are ~9% of small cell carcinoma | ||
|} | |} | ||